Literature DB >> 28748158

Bioresorbable vascular scaffolds for complex coronary anatomies: "Icarus' flight" for interventional cardiologists?

Salvatore Cassese1, Adnan Kastrati1,2, Massimiliano Fusaro1.   

Abstract

Year:  2017        PMID： 28748158      PMCID： PMC5509928          DOI： 10.21037/cdt.2017.01.10

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  20 in total

1.  Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.

Authors:  Serban Puricel; Florim Cuculi; Melissa Weissner; Axel Schmermund; Peiman Jamshidi; Tobias Nyffenegger; Harald Binder; Holger Eggebrecht; Thomas Münzel; Stephane Cook; Tommaso Gori
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

2.  ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.

Authors:  Salvatore Brugaletta; Tommaso Gori; Adrian F Low; Petr Tousek; Eduardo Pinar; Josep Gomez-Lara; Luis Ortega-Paz; Eberhard Schulz; Mark Y Chan; Viktor Kocka; Jose Hurtado; Joan Antoni Gomez-Hospital; Giuseppe Giacchi; Thomas Münzel; Chi-Hang Lee; Angel Cequier; Mariano Valdés; Petr Widimsky; Patrick W Serruys; Manel Sabaté
Journal:  Int J Cardiol       Date:  2016-04-07       Impact factor: 4.164

3.  Bioresorbable Vascular Scaffolds for Coronary Revascularization.

Authors:  Dean J Kereiakes; Yoshinobu Onuma; Patrick W Serruys; Gregg W Stone
Journal:  Circulation       Date:  2016-07-12       Impact factor: 29.690

Review 4.  Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.

Authors:  Luca Testa; Azeem Latib; Rocco A Montone; Antonio Colombo; Francesco Bedogni
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

5.  Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.

Authors:  Salvatore Cassese; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

6.  Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy.

Authors:  Akihito Tanaka; Azeem Latib; Hiroyoshi Kawamoto; Richard J Jabbour; Katsumasa Sato; Tadashi Miyazaki; Toru Naganuma; Antonio Mangieri; Matteo Pagnesi; Claudio Montalto; Alaide Chieffo; Mauro Carlino; Matteo Montorfano; Antonio Colombo
Journal:  EuroIntervention       Date:  2017-02-20       Impact factor: 6.534

7.  Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria.

Authors:  Robin P Kraak; Maik J Grundeken; Mariëlla E Hassell; Joëlle Elias; Karel T Koch; José P Henriques; Jan J Piek; Jan Baan; Marije M Vis; Jan G P Tijssen; Robbert J de Winter; Joanna J Wykrzykowska
Journal:  EuroIntervention       Date:  2016-08-05       Impact factor: 6.534

Review 8.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

9.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Stephen G Ellis; Dean J Kereiakes; D Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  N Engl J Med       Date:  2015-10-12       Impact factor: 91.245

Review 10.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.